Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aveo Pharmaceuticals Inc (NASDAQ:AVEO)

1.40
Delayed Data
As of Aug 27
 +0.07 / +5.26%
Today’s Change
0.61
Today|||52-Week Range
3.50
+66.63%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues1.8M873.0K115.0K134.0K
 
 
 
 
 
Depreciation And Amortization852.0K1.1M--4.5M
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses13.3M12.5M11.8M1.5M
 
 
 
 
 
Research And Development8.4M8.5M8.7M451.0K
 
 
 
 
 
Total Operating Expenses14.1M13.6M11.8M6.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-12.3M-12.7M-11.7M-5.8M
 
 
 
 
 
Extraordinary Charge-5.2M-1.4M-1.3M-4.3M
 
 
 
 
 
Interest Expense On Debt502.0K439.0K866.0K716.0K
 
 
 
 
 
Other Expenses-2.0K98.0K-37.0K-14.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-18.0M-14.4M-13.9M-10.9M
 
 
 
 
 
Net Income-18.0M-14.4M-13.9M-10.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS51.7M51.8M51.8M52.6M
 
 
 
 
 
Shares To Calculate EPS Diluted51.7M51.8M51.8M52.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.35-$0.28-$0.27-$0.21
 
 
 
 
 
EPS Diluted-$0.35-$0.28-$0.27-$0.21